Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Stopped early · Phase 2

Conditions studied: Cancer, Hepatic Injury

In brief

The purposes of this study are to make Omegaven® available to cancer patients with liver disease and to determine if Omegaven® can improve or prevent further liver disease. The study will also look at the effects Omegaven® has on immune function.

Key facts

Study ID
NCT01325584
Run by
Midwestern Regional Medical Center
People needed
12
Starts
2012-10-01
Expected to finish
2017-04-01
Last updated by the study team
2018-08-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.